ModraDoc006/r in Patients With Breast Cancer
Clinical trial NCT03890744 · COMPLETED
Trial details
- NCT number
- NCT03890744
- Sponsor
- Modra Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-30
- Primary completion
- 2020-02-13
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.